Current management of pregnant women with bleeding disorders relies on raising deficient clotting factor levels (e.g., VWF/FVIII concentrates in VWD, platelet transfusions in platelet disorders, etc.)and close monitoring by a multidisciplinary team [5]. Here, VWF is linked to hemorrhagic disease.